Today's Top Gainer
Note:Top Gainer - Nifty 50 More
CARE has triggers in place to grow in tandem with India’s credit growth story. The near term could be volatile due to ...
Buy Reco. Price: 1,286.25
USFDA has barred entry of drugs manufactured at Ipca’s troubled facilities (Ratlam, Indore SEZ and Silvassa). Ipca expects ...
Reduce Reco. Price: 744